HR 5213 RDS 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Research Review Act 
of 2004’’. 
SEC. 2. MULTI-DISCIPLINARY RESEARCH TEAM AND CON-
SORTIA REPORT. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this Act as the ‘‘Sec-
retary’’), in coordination with the Director of the National 
Institutes of Health, shall prepare a report outlining the 
methods by which the Roadmap for Medical Research, an 
initiative of such Institutes, has advanced the use of multi-
disciplinary research teams and consortia of research in-
stitutions to advance treatments, develop new therapies, 
and collaborate on clinical trials, including with respect 
to spinal cord injury and paralysis research. 
(b) REPORT.—Not later than February 1, 2005, the 
Secretary shall submit the report under subsection (a) to 
the Committee on Energy and Commerce of the House 
of Representatives and to the Committee on Health, Edu-
cation, Labor, and Pensions of the Senate. 
SEC. 3. EPIDEMIOLOGICAL STUDY REPORT. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall prepare a report outlining the epidemiological 
studies currently under way at such Centers, future 
planned studies, the criteria involved in determining what
HR 5213 RDS 
epidemiological studies to conduct, defer, or suspend, and 
the scope of those studies, including with respect to the 
inflammatory bowel disease epidemiological study. The re-
port shall include a description of the activities the Cen-
ters for Disease Control and Prevention undertakes to es-
tablish partnerships with research and patient advocacy 
communities to expand epidemiological studies. 
(b) REPORT.—Not later than May 1, 2005, the Sec-
retary shall submit the report under subsection (a) to the 
Committee on Energy and Commerce of the House of 
Representatives and to the Committee on Health, Edu-
cation, Labor, and Pensions of the Senate. 
SEC. 4. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE 
ON MEDICARE AND MEDICAID COVERAGE 
STANDARDS. 
(a) IN GENERAL.—The Comptroller General of the 
United States shall conduct a study on the coverage stand-
ards that, under the programs under titles XVIII and XIX 
of the Social Security Act (commonly known as Medicare 
and Medicaid, respectively), apply to patients with inflam-
matory bowel disease for the following therapies: 
(1) Parenteral nutrition. 
(2) Enteral nutrition formula. 
(3) Medically necessary food products. 
(4) Ostomy supplies.
HR 5213 RDS 
(5) Therapies approved by the Food and Drug 
Administration for Crohn’s disease and ulcerative 
colitis. 
(b) CONTENT.—The study under subsection (a) shall 
take into account the appropriate outpatient or home 
health care delivery settings. 
(c) REPORT.—Not later than six months after the 
date of the enactment of this Act, the Comptroller General 
shall submit to the Congress a report describing the find-
ings of the study under subsection (a). 
SEC. 5. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE 
INVOLVING DISABILITY INSURANCE. 
(a) IN GENERAL.—The Comptroller General of the 
United States shall conduct a study of the problems pa-
tients encounter when applying for disability insurance 
benefits under title II of the Social Security Act. The 
study shall include recommendations for improving the ap-
plication process for patients with inflammatory bowel dis-
ease. 
(b) REPORT.—Not later than six months after the 
date of the enactment of this Act, the Comptroller General
HR 5213 RDS 
shall submit to the Congress a report describing the find-
ings of the study under subsection (a).
Passed the House of Representatives October 7, 
2004. 
Attest: 
JEFF TRANDAHL, 
Clerk.